Association of thromboxane A2 receptor gene polymorphism with the phenotype of acetyl salicylic acid-intolerant asthma - Wikidata - awgldk - TriplyDB

Association of thromboxane A2 receptor gene polymorphism with the phenotype of acetyl salicylic acid-intolerant asthma

Association of thromboxane A2 receptor gene polymorphism with the phenotype of acetyl salicylic acid-intolerant asthma

http://www.wikidata.org/entity/Q28175608

about

Update on the Management of Aspirin-Exacerbated Respiratory Disease What we know about nonsteroidal anti-inflammatory drug hypersensitivity Cysteinyl Leukotrienes Pathway Genes, Atopic Asthma and Drug Response: From Population Isolates to Large Genome-Wide Association Studies Pharmacogenomics of Prostaglandin and Leukotriene Receptors Genetic markers for differentiating aspirin-hypersensitivity Aspirin and decreased adult-onset asthma: randomized comparisons from the physicians' health study G-protein-coupled receptors and asthma endophenotypes: the cysteinyl leukotriene system in perspective CysLTR1 promoter polymorphism and requirement for leukotriene receptor antagonist in aspirin-intolerant asthma patients Genome-wide and follow-up studies identify CEP68 gene variants associated with risk of aspirin-intolerant asthma.Fatty acid binding protein 1 is related with development of aspirin-exacerbated respiratory disease.Site-directed mutations and the polymorphic variant Ala160Thr in the human thromboxane receptor uncover a structural role for transmembrane helix 4 Exonic variants associated with development of aspirin exacerbated respiratory diseases.Pulmonary surfactant phosphatidylglycerol inhibits Mycoplasma pneumoniae-stimulated eicosanoid production from human and mouse macrophages Elevation of Eosinophil-Derived Neurotoxin in Plasma of the Subjects with Aspirin-Exacerbated Respiratory Disease: A Possible Peripheral Blood Protein Biomarker.Diagnostic value of clinical parameters in the prediction of aspirin-exacerbated respiratory disease in asthma.Contribution of the OBSCN nonsynonymous variants to aspirin exacerbated respiratory disease susceptibility in Korean population.Pharmacogenetics of aspirin-intolerant asthma.Update on recent advances in the management of aspirin exacerbated respiratory disease.Cysteinyl leukotriene receptors, old and new; implications for asthma.Pathogenesis of aspirin-exacerbated respiratory disease and reactions.Unraveling the genetic basis of aspirin hypersensitivity in asthma beyond arachidonate pathways.Revisiting the usefulness of thromboxane-A2 modulation in the treatment of bronchoconstriction in asthma.Association between thromboxane A2 receptor polymorphisms and asthma risk: A meta-analysis.Aspirin-exacerbated respiratory disease and current treatment modalities.Association of thromboxane A2 receptor (TBXA2R) gene polymorphism in patients with aspirin-intolerant acute urticaria.Genetic mechanisms in aspirin-exacerbated respiratory disease.Association analysis of thromboxane A synthase 1 gene polymorphisms with aspirin intolerance in asthmatic patients.Attempted replication of 50 reported asthma risk genes identifies a SNP in RAD50 as associated with childhood atopic asthma.Functional variants in the thromboxane A2 receptor gene are associated with lung function in childhood-onset asthma.Association analysis of ILVBL gene polymorphisms with aspirin-exacerbated respiratory disease in asthma.Genetic variants in arachidonic acid pathway genes associated with NSAID-exacerbated respiratory disease.Clinical course of patients with aspirin-exacerbated respiratory disease: can we predict the prognosis?Genome-wide association study of aspirin-exacerbated respiratory disease in a Korean population.Samter's Triad: State of the Art.

P2860

Q26749097-4BC547C3-6D7B-458C-AF86-3AAF8AA10F98 Q26749250-4BAE10A3-2625-4405-B6F5-69593E6C12CF Q28067073-5FC457A2-9C8F-40F0-B832-84119F46E5DC Q28077789-06B77216-02EE-4353-9F4B-7511B65E5BB3 Q28195398-9E7F5695-7A0C-4EA3-888A-9698354430A5 Q28201262-03EA624B-B474-4522-8F15-4AE08F5DB183 Q28212087-0AAA29AD-82C3-4754-94B1-853B14A4C0E3 Q28222532-C1F3DCE8-B520-4F48-AE23-7CB3C13E7A2C Q30396182-F96D61CC-4345-400D-99CB-8F8794814560 Q33988507-6C1947DB-EC27-40B8-B675-FE5416B642CC Q34137445-50D74791-6C69-47A2-9614-65BE7784CE83 Q34457070-F6F42EA8-17F6-41B9-9D0F-354F5A824A4F Q34624136-57D11A84-3FF0-46DD-B46B-B8718A632A13 Q34785484-54ECF961-8988-4FC8-A226-9BAFECC95E82 Q35228588-62DFC5DA-9057-4E03-8E70-D5796F9BA38A Q36045148-726910B7-82D3-43FF-AE13-AF18CDF33799 Q37043508-63BC0ACF-BBAA-4D2B-87FE-A65371D0AE47 Q37485583-9847767A-DB59-49E1-82CF-1DEF80E97B6E Q38038319-C10B71A6-D5D2-49ED-BC7C-3454BBC226FA Q38103710-02907B15-2460-49A0-ADC5-C646BF92B150 Q38134073-24D14D86-E41C-4A0F-993D-3EEDEAB5F024 Q38315250-00A44FDA-E1C2-45A3-80C5-9D383C20EEE3 Q38381525-E10D003E-B7D1-48E0-AB7B-8A537D988A67 Q38931124-4DA036FE-B12D-40EE-B899-905A8E869AF5 Q39633087-1D5A333A-E49C-41D5-B7AB-490983257FED Q39718340-596C3971-F047-4470-8183-361C54C219AC Q42744363-A91CF7AE-2DF3-4B3F-A851-28FEC535008F Q45349008-4951CFFD-F9F2-4924-8A48-320C708F8B64 Q46210387-4E479A2F-C73D-4EB3-8615-EF28773DA583 Q47159407-4EE4F1A2-13F8-4A63-822C-8929D8ABA7A9 Q51622794-EEC934E3-EA4E-4D2A-8D59-83DE13BD4A3D Q53291503-92359EB5-CEC9-4A9D-B79F-D1F95D27E49F Q53352652-260C4F2B-6BB0-49FE-8FBC-7693920D1067 Q54940852-BFA98176-997E-4E6A-A87E-A01B521CF992

P2860

Association of thromboxane A2 receptor gene polymorphism with the phenotype of acetyl salicylic acid-intolerant asthma

http://www.wikidata.org/entity/Q28175608

description

2005 nî lūn-bûn

@nan

2005 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Association of thromboxane A2 ...... licylic acid-intolerant asthma

@ast

Association of thromboxane A2 ...... licylic acid-intolerant asthma

@en

Association of thromboxane A2 ...... licylic acid-intolerant asthma

@nl

type

label

Association of thromboxane A2 ...... licylic acid-intolerant asthma

@ast

Association of thromboxane A2 ...... licylic acid-intolerant asthma

@en

Association of thromboxane A2 ...... licylic acid-intolerant asthma

@nl

prefLabel

Association of thromboxane A2 ...... licylic acid-intolerant asthma

@ast

Association of thromboxane A2 ...... licylic acid-intolerant asthma

@en

Association of thromboxane A2 ...... licylic acid-intolerant asthma

@nl

P1433

Q28175608-5990F916-5B20-4281-BF0A-2DB4E6C448D3

P1476

Q28175608-B68BF78F-458E-410D-9D6F-B68C69838ADE

P2093

Q28175608-3705BF0B-F18C-4A5E-8902-54407C7FEF8B

Q28175608-40A44643-1161-4430-89A8-5B78E96E70CF

Q28175608-7CF9C582-2D0F-4C9F-A0F9-1E08B98EBDEE

Q28175608-9BF29C56-6C6E-489D-BD89-CCE755D7C831

Q28175608-C787A14A-133A-49A7-B679-AC5AC8960F01

P2860

Q28175608-0ED74E99-EB87-44A6-9998-4E01F5583AB9

Q28175608-173D373E-D160-4674-ADDE-C98AB28B49F4

Q28175608-23AD4B35-6A9B-4519-BAA4-7B67FB5D230F

Q28175608-70581107-2ED5-4A49-B79C-314568033A0D

Q28175608-7D91F69F-76DE-44B4-984B-FA79811D0175

Q28175608-8C34E6C2-E815-47CA-80B3-28FECA9FB142

Q28175608-8E8A0854-65F9-4C8D-8357-928D7E3D84DB

Q28175608-96091414-D353-41D2-B5D9-1B976D00A040

Q28175608-B5CBA1F7-3AC9-4FA2-89C6-E8D306E7B609

Q28175608-B8E5663A-29E6-4E68-98A5-F9BD00DD3B79

P304

Q28175608-21310D40-A6DE-446A-879F-9B8608BECA53

P31

Q28175608-48B420B1-2F78-4964-BB36-B516FC868BB9

P3181

Q28175608-1EAB872D-2671-4922-93A5-B4ADD7CBEA60

P356

Q28175608-392F8E23-DC19-42F8-AA3E-677FBEB87F20

P407

Q28175608-5E44DEDD-3624-481B-9382-8BC43E26CD1B

P433

Q28175608-3211464F-1D9D-438A-9712-A6E9BDF26926

P478

Q28175608-62BE084E-873C-4914-8301-4C5C99AAFB39

P50

Q28175608-ED0C2594-3296-46FC-AF6B-E6D32B65381C

Q28175608-F3551EE7-B1C6-4709-8147-C8EEB5CBF181

P577

Q28175608-0FAEFF2B-BC10-482F-A36C-447B53A505E7

P5875

Q28175608-6E93007C-3F40-4773-9A5F-E50595B0CF07

P698

Q28175608-11FBB3A2-7849-40AA-B227-E2D7B58F4384

P921

Q28175608-B6E43606-6D33-46B3-AF5F-630F2E47B808

P3181

P356

J.1365-2222.2005.02220.X

P1433

Clinical & Experimental Allergy

P1476

Association of thromboxane A2 ...... licylic acid-intolerant asthma

@en

P2093

Choi JH

http://www.w3.org/2001/XMLSchema#string

Lee SK

http://www.w3.org/2001/XMLSchema#string

Park CS

http://www.w3.org/2001/XMLSchema#string

Park HS

http://www.w3.org/2001/XMLSchema#string

Shin HD

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice

Haploview: analysis and visualization of LD and haplotype maps

Leukotriene-related gene polymorphisms in ASA-intolerant asthma: an association with a haplotype of 5-lipoxygenase

HLA association in aspirin-intolerant asthma: DPB1*0301 as a strong marker in a Korean population

Release of cysteinyl leukotrienes with aspirin stimulation and the effect of prostaglandin E(2) on this release from peripheral blood leucocytes in aspirin-induced asthmatic patients

Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma

Uncoupled regulation of leukotriene C4 synthase in platelets from aspirin-intolerant asthmatics and healthy volunteers after aspirin treatment

Advance in understanding the biosynthesis of prostacyclin and thromboxane A2 in the endoplasmic reticulum membrane via the cyclooxygenase pathway.

Genetic variants of the receptors for thromboxane A2 and IL-4 in atopic dermatitis.

Thromboxane A2 receptor gene polymorphism is associated with the serum concentration of cat-specific immunoglobulin E as well as the development and severity of asthma in Chinese children.

P304

585-590

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

287979

http://www.w3.org/2001/XMLSchema#string

P356

10.1111/J.1365-2222.2005.02220.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P50

John W. Holloway

P577

2005-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7842519

http://www.w3.org/2001/XMLSchema#string

P698

15898979

http://www.w3.org/2001/XMLSchema#string

P921